Diego Alignani
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 31
- Acute Myeloid Leukemia Research 8
- Immunology 30
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 10
- Immunotherapy and Immune Responses 9
- Co-authors
- Belkys Angélica Maletto (5 shared papers)María Cristina Pistoresi-Palencia (5 shared papers)Andrea Silvana Ropolo (3 shared papers)Ignacio Melero (3 shared papers)Carlos Alfaro (2 shared papers)Pedro Berraondo (3 shared papers)Guiomar Pérez (2 shared papers)Carmen Oñate (2 shared papers)
- Journals
- Blood (25 papers)Leukemia (5 papers)Haematologica (4 papers)Blood Advances (3 papers)Nature Communications (3 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Diego Alignani
75 papers receiving 3.2k citations
Diego Alignani's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 826
- Immunology 1.1k
- Oncology 996
- Genetics 294
- Cancer Research 255
Countries citing papers authored by Diego Alignani
This map shows the geographic impact of Diego Alignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Alignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Alignani more than expected).
Fields of papers citing papers by Diego Alignani
This network shows the impact of papers produced by Diego Alignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Alignani. The network helps show where Diego Alignani may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Alignani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs) Hit paper breakdown → | 2016 | 362 |
| 2 | 2015 | 260 | |
| 3 | 2020 | 185 | |
| 4 | 2019 | 182 | |
| 5 | 2006 | 122 | |
| 6 | 2017 | 115 | |
| 7 | 2020 | 114 | |
| 8 | 2020 | 110 | |
| 9 | 2020 | 108 | |
| 10 | 2017 | 100 | |
| 11 | 2021 | 92 | |
| 12 | 2016 | 89 | |
| 13 | 2016 | 82 | |
| 14 | 2019 | 76 | |
| 15 | 2015 | 76 | |
| 16 | 2010 | 71 | |
| 17 | 2022 | 71 | |
| 18 | 2005 | 59 | |
| 19 | 2019 | 51 | |
| 20 | 2019 | 50 |
About Diego Alignani
Diego Alignani is a scholar working on Hematology, Immunology, Oncology, Cancer Research and Genetics, having authored 78 papers that have together received 3.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (10 papers), CAR-T cell therapy research (9 papers), Protein Degradation and Inhibitors (9 papers), Immunotherapy and Immune Responses (9 papers), Acute Myeloid Leukemia Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Hematology (826 citations), Immunology (1.1k citations), Oncology (996 citations), Genetics (294 citations) and Cancer Research (255 citations). Diego Alignani has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Belkys Angélica Maletto, María Cristina Pistoresi-Palencia, Andrea Silvana Ropolo, Ignacio Melero, Carlos Alfaro, Pedro Berraondo, Guiomar Pérez, Carmen Oñate, Miguel Fernandez de Sanmamed and Sandra Hervás‐Stubbs. Their work appears in journals such as Blood, Leukemia, Haematologica, Blood Advances and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.